Metagenics (Aliso Viejo, CA) has named Patrick Sly as CEO, effective immediately. A highly regarded executive in the health and wellness industry, Sly brings a wealth of relevant leadership experience to Metagenics. Current President and CEO Pat Smallcombe, who has led Metagenics through a period of tremendous growth since 2023, will transition to the role of Co-chair of the Board. Metagenics is backed by Gryphon Investors, a leading middle-market private investment firm.
“With Patrick’s deep experience in medical nutrition, partnerships with health care professionals, and leadership of global businesses, I couldn’t imagine a stronger candidate to succeed Pat Smallcombe’s successful tenure,” said Ryan Fagan, deal partner in Gryphon’s Consumer Group. “Patrick’s leadership style focuses on integrity, innovation and collaboration, an ideal fit for Metagenics’ culture.”
Sly most recently served as global president of Reckitt’s $8 billion consumer health division, where he led the portfolio to industry-leading profitability, renewed market share momentum, and durable growth. He previously served as global president of Reckitt’s $3 billion nutrition business, delivering a major global turnaround that strengthened margins, accelerated growth and restored competitiveness.
Sly earned his MBA from Washington University in St. Louis’ Olin Business School and his Bachelor of Science in Business from Indiana University’s Kelley School of Business.
“I’m thrilled to be joining Metagenics at such an exciting time,” said Sly. “The professional segment of the supplements category has tremendous growth potential, and Metagenics’ outstanding brand and clinically tested product line position the company for continued success. I’m especially impressed by the very strong team and solid foundation that Pat Smallcombe has built, and I look forward to working with the organization to drive the next phase of growth.”
For more information, visit www.metagenics.com.
